President Trump nominated Alex Azar as his Secretary of Health and Human Services. The President tweeted that the new Secretary would lower the drug prices as he promised in his Presidential campaign.
Azar, however, as the former executive at Eli Lilly, is accused of raising the prices of drugs.
The US drug prices are by far more expensive than in any other developed nations.
Happy to announce, I am nominating Alex Azar to be the next HHS Secretary. He will be a star for better healthcare and lower drug prices!— Donald J. Trump (@realDonaldTrump) November 13, 2017
Azar, however, as the former executive at Eli Lilly, is accused of raising the prices of drugs.
Red flag. While an executive at Eli Lilly, Alex Azar, Trump’s new HHS pick, oversaw questionable spikes in insulin prices. https://t.co/83sxIyGDg1— Kirsten Gillibrand (@SenGillibrand) November 13, 2017
The US drug prices are by far more expensive than in any other developed nations.
